Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Observational study of long-term follow-up of patients previously participating in the ProTrans-2 clinical trial

Next Previous
X
Search
Trial Profile

Observational study of long-term follow-up of patients previously participating in the ProTrans-2 clinical trial

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mesenchymal-stem-cell-therapy NextCell-Pharma (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms ProTrans-OBS
  • Sponsors NextCell Pharma

    • Most Recent Events

    • 30 May 2023 According to a Nextcell pharma media release, data from this study will be presented at the ISCT meeting by Dr Davies.
    • 18 Apr 2023 According to a Nextcell pharma media release, data from this study is expected to present at the European Wound Management Association Meeting, by Dr Lindsay Davies.
    • 28 Sep 2022 According to a Nextcell pharma media release, the company is expected to present the 3-year long-term data from this study in October 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top